{"id":71470,"date":"2026-05-20T11:55:00","date_gmt":"2026-05-20T11:55:00","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=71470"},"modified":"2026-10-15T10:33:56","modified_gmt":"2026-10-15T10:33:56","slug":"l-glutathione-reduced-gsh","status":"publish","type":"product","link":"https:\/\/medsbase.com\/fr\/product\/l-glutathione-reduced-gsh\/","title":{"rendered":"L-Glutathione (Reduced \/ GSH) Injectable \u2014 Pharmaceutical Grade"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">R\u00e9ponse rapide \u2014 Qu'est-ce que le glutathion (GSH) ?<\/h3>\n<p style=\"margin: 0;\"><strong>L-Glutathion (r\u00e9duit ; GSH)<\/strong> est le tripeptide \u03b3-glutamyl-cyst\u00e9inyl-glycine (\u03b3-Glu-Cys-Gly), CAS 70-18-8, formule mol\u00e9culaire C<sub>10<\/sub>H<sub>17<\/sub>N<sub>3<\/sub>O<sub>6<\/sub>S, MW 307.32 g\/mol. GSH is the most abundant non-protein cellular thiol (millimolar intracellular concentrations) and the canonical reference compound for cellular antioxidant defence studies. The unique <strong>\u03b3<\/strong> between glutamate&#8217;s \u03b3-carboxyl and cysteine&#8217;s amino group (rather than the standard \u03b1-peptide bond) makes GSH resistant to common peptidases \u2014 only \u03b3-glutamyltransferase (\u03b3-GT) can cleave it. Cells use GSH as the primary electron donor for glutathione peroxidase-mediated hydrogen-peroxide reduction, as the conjugating co-substrate for glutathione-S-transferase-mediated xenobiotic detoxification, and as the redox-status buffer that controls protein thiol-disulfide equilibrium. Supplied here as lyophilized USP-grade powder for clinical studies use only.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Ce que vous obtenez avec MedsBase :<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/fr\/reviews\/\">avis clients<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Chaque commande est couverte par notre <a href=\"https:\/\/medsbase.com\/fr\/medsbase-re-shipment-assurance-policy\/\"><strong>Politique de R\u00e9exp\u00e9ditions Garanties<\/strong><\/a> \u2014 si votre colis n'arrive pas dans les 20 jours ouvrables, nous le r\u00e9exp\u00e9dions.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Sp\u00e9cification<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">D\u00e9tail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Classe de compos\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u03b3-Glutamyl tripeptide; primary cellular non-protein thiol antioxidant; small-molecule peptide (\u03b3-linked, peptidase-resistant)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Nom chimique<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">L-Glutathion, r\u00e9duit (\u03b3-L-Glutamyl-L-cyst\u00e9inyl-glycine ; synonymes : GSH, acide glutathion libre, glutathion r\u00e9duit)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Num\u00e9ro CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">70-18-8 (forme r\u00e9duite GSH) ; apparent\u00e9 : 27025-41-8 (forme dim\u00e8re oxyd\u00e9e GSSG, non fournie ici)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Formule mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>10<\/sub>H<sub>17<\/sub>N<sub>3<\/sub>O<sub>6<\/sub>S<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Masse mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">307,32 g\/mol (acide libre)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>S\u00e9quence<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u03b3-L-Glutamyl-L-cyst\u00e9inyl-glycine (\u03b3-Glu-Cys-Gly). Notez la <strong>\u03b3<\/strong> entre la cha\u00eene lat\u00e9rale \u03b3-COOH du glutamate et le groupe \u03b1-amin\u00e9 de la cyst\u00e9ine, plut\u00f4t que la liaison peptidique \u03b1 standard. Cette liaison non standard est ce qui rend le GSH r\u00e9sistant aux \u03b1-peptidases communes \u2014 seule la \u03b3-glutamyltransf\u00e9rase (\u03b3-GT) le clive, ce qui est l'\u00e9tape limitante de la d\u00e9gradation et du recyclage extracellulaires du GSH.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>M\u00e9canisme<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\"><strong>Trois r\u00f4les cellulaires principaux<\/strong>. (1) <em>Donneur d'\u00e9lectrons pour la glutathion peroxydase<\/em> (famille GPx) \u2014 2 GSH + H<sub>2<\/sub>O<sub>2<\/sub> \u2192 GSSG + 2 H<sub>2<\/sub>O, la r\u00e9action canonique de r\u00e9duction du peroxyde d'hydrog\u00e8ne cellulaire ; le GSSG est ensuite r\u00e9duit en 2 GSH par la glutathion r\u00e9ductase d\u00e9pendante du NADPH. (2) <em>Co-substrat pour la glutathion-S-transf\u00e9rase<\/em> (Famille GST) \u2014 conjugue le GSH \u00e0 des substrats x\u00e9nobiotiques et endog\u00e8nes \u00e9lectrophiles, g\u00e9n\u00e9rant des conjugu\u00e9s mercapturiques excr\u00e9tables (voie centrale de d\u00e9toxification h\u00e9patique). (3) <em>Tampon du statut redox<\/em> \u2014 le ratio GSH:GSSG (typiquement ~100:1 dans les cellules saines) contr\u00f4le l'\u00e9quilibre thiol-disulfure des prot\u00e9ines via des \u00e9changes m\u00e9di\u00e9s par la thioredoxine et la glutar\u00e9doxine, r\u00e9gulant ainsi des milliers d'activit\u00e9s prot\u00e9iques sensibles au redox.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forme<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilized white-to-off-white crystalline powder; single-use vials. <strong>Tr\u00e8s hygroscopique<\/strong> \u2014 refermez les flacons imm\u00e9diatement apr\u00e8s chaque pr\u00e9l\u00e8vement pour \u00e9viter l'absorption d'humidit\u00e9.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Puret\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (v\u00e9rifi\u00e9 par HPLC, certificat d'analyse sur demande) ; titrage confirmant \u226598% de GSH r\u00e9duit (\u22642% de GSSG oxyd\u00e9). R\u00e9f\u00e9rence qualit\u00e9 USP.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilit\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Eau 20 mg\/mL ; PBS (pH 7,2) 10 mg\/mL \u2014 facilement soluble aux concentrations fournies en flacon. Le groupe thiol (-SH) rend le GSH sensible \u00e0 l'oxydation \u00e0 l'air \u2014 pr\u00e9parez des solutions de travail fra\u00eeches \u00e0 partir du flacon lyophilis\u00e9 et utilisez-les dans les 24 heures si possible. Le DMSO est un co-solvant appropri\u00e9 pour la pr\u00e9paration de stocks en culture cellulaire (jusqu'\u00e0 100 mg\/mL) et offre une protection suppl\u00e9mentaire contre l'oxydation \u00e0 l'air.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Stockage<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilis\u00e9 : 2\u20138 \u00b0C dans l'emballage scell\u00e9 d'origine pour les stocks de travail \u00e0 court terme ; \u221220 \u00b0C pour le stockage \u00e0 long terme des flacons non ouverts (stable \u226536 mois \u00e0 \u221220 \u00b0C ; \u226518 mois \u00e0 2\u20138 \u00b0C). Solutions aqueuses reconstitu\u00e9es : 2\u20138 \u00b0C, \u00e0 utiliser dans ~7 jours (l'oxydation \u00e0 l'air en GSSG est le facteur limitant). Prot\u00e9ger de la lumi\u00e8re. <strong>\u00c9vitez les cycles r\u00e9p\u00e9t\u00e9s de cong\u00e9lation-d\u00e9cong\u00e9lation des solutions reconstitu\u00e9es<\/strong> \u2014 les cycles cumulatifs acc\u00e9l\u00e8rent l'oxydation GSH \u2192 GSSG.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Qu'est-ce que la L-Glutathion (r\u00e9duite \/ GSH) ?<\/h2>\n<p><strong>L-Glutathion (forme r\u00e9duite, GSH)<\/strong> est le thiol cellulaire non prot\u00e9ique le plus abondant en biologie eucaryote \u2014 pr\u00e9sent \u00e0 des concentrations intracellulaires millimolaires (1\u201310 mM dans la plupart des types cellulaires ; jusqu'\u00e0 10 mM dans les h\u00e9patocytes) et servant de tampon mol\u00e9culaire principal pour le statut redox cellulaire. Structurellement, c'est un tripeptide de glutamate, de cyst\u00e9ine et de glycine (\u03b3-Glu-Cys-Gly), CAS 70-18-8, formule mol\u00e9culaire C<sub>10<\/sub>H<sub>17<\/sub>N<sub>3<\/sub>O<sub>6<\/sub>S, molecular weight 307.32 g\/mol. The defining structural feature of glutathione is its <strong>\u03b3<\/strong>. Les peptides standards sont li\u00e9s par des liaisons peptidiques \u03b1 entre le \u03b1-carboxyle d'un acide amin\u00e9 et le \u03b1-amino du suivant. Dans le glutathion, la liaison entre le glutamate et la cyst\u00e9ine est non conventionnelle : elle est form\u00e9e entre le <em>\u03b3-carboxyle<\/em> of glutamate&#8217;s side chain and the \u03b1-amino of cysteine. This non-standard linkage is the molecular basis for glutathione&#8217;s resistance to common cellular peptidases \u2014 only \u03b3-glutamyltransferase (\u03b3-GT, GGT, EC 2.3.2.2) recognises and cleaves the \u03b3-bond. As a result, glutathione is uniquely stable in the cellular cytosol where it would otherwise be rapidly degraded by \u03b1-peptidase activity, and \u03b3-GT-mediated extracellular degradation is the rate-limiting step of glutathione recycling. Glutathione is synthesised in two ATP-dependent steps by the cytosolic enzymes <strong>glutamate-cyst\u00e9ine ligase (GCL)<\/strong> \u2014 qui forme la liaison \u03b3-glutamyl-cyst\u00e9ine \u2014 et <strong>glutathion synth\u00e9tase (GSS)<\/strong> \u2014 which adds the C-terminal glycine. GCL is the rate-limiting enzyme and is feedback-inhibited by glutathione itself, providing autoregulation of cellular glutathione levels. Cysteine availability is the other major rate-limiting input \u2014 which is why N-acetylcysteine (NAC), a cysteine prodrug, is the canonical clinical intervention for boosting cellular glutathione synthesis in oxidative-stress and detoxification contexts (the basis of NAC&#8217;s approval for paracetamol overdose and other clinical indications). Glutathione exists in cells in two interconverting forms: the <strong>forme r\u00e9duite (GSH)<\/strong> avec un groupe thiol libre (-SH), et la <strong>forme oxyd\u00e9e (GSSG)<\/strong> o\u00f9 deux mol\u00e9cules de GSH sont li\u00e9es par un pont disulfure. Le rapport GSH:GSSG (typiquement ~100:1 dans les cellules saines, chutant \u00e0 10:1 ou moins sous stress oxydatif) est le biomarqueur redox cellulaire canonique. Le GSSG est r\u00e9duit en 2 GSH par <strong>la glutathion r\u00e9ductase (GR, GSR)<\/strong>, an NADPH-dependent flavoenzyme \u2014 connecting the GSH redox system to NADPH availability and ultimately to the pentose phosphate pathway. This is why pentose-phosphate-pathway disruption (G6PD deficiency, glucose-6-phosphate availability) impairs GSH-system function and triggers oxidative cell damage. The pharmaceutical-grade material supplied here is the reduced GSH form, supplied as lyophilized powder for reconstitution and protocol use alongside the peptide catalogue. <\/p>\n<h2>M\u00e9canisme d'action \u2014 Trois r\u00f4les cellulaires primaires<\/h2>\n<p>Le m\u00e9canisme biologique du GSH est la somme de trois r\u00f4les cellulaires primaires qui sont tous bien caract\u00e9ris\u00e9s dans la biochimie publi\u00e9e :<\/p>\n<ul>\n<li><strong>Substrat de la glutathion peroxydase (GPx) \u2014 r\u00e9duction du peroxyde d'hydrog\u00e8ne et des peroxydes lipidiques<\/strong> \u2014 Le r\u00f4le le plus cit\u00e9 du GSH. La famille des GPx (GPx1\u20138, avec la GPx1 d\u00e9pendante du s\u00e9l\u00e9nium la plus abondante) catalyse la r\u00e9action <em>2 GSH + ROOH \u2192 GSSG + ROH + H<sub>2<\/sub>O<\/em>, r\u00e9duisant le peroxyde d'hydrog\u00e8ne et les hydroperoxydes lipidiques en eau et alcools respectivement. C'est la principale d\u00e9fense de la cellule contre les esp\u00e8ces r\u00e9actives de l'oxyg\u00e8ne g\u00e9n\u00e9r\u00e9es par la respiration mitochondriale, l'activit\u00e9 de la NADPH-oxydase et d'autres processus oxydatifs. La GPx4 est l'isoforme sp\u00e9cifique qui catalyse la r\u00e9duction des hydroperoxydes lipidiques et est la cible mol\u00e9culaire dont la perte de fonction d\u00e9clenche <strong>ferroptose<\/strong> \u2014 the iron-dependent regulated cell death pathway that has become a major focus of recent cancer-studies and neurodegenerative-disease studies.<\/li>\n<li><strong>Co-substrat de la glutathion-S-transf\u00e9rase (GST) \u2014 conjugaison de x\u00e9nobiotiques et d'endobiotiques<\/strong> \u2014 La famille GST (membres cytosoliques, microsomiaux et mitochondriaux ; ~20 isoformes humaines de GST) catalyse la conjugaison du GSH \u00e0 des substrats \u00e9lectrophiles via le groupe thiol du GSH, g\u00e9n\u00e9rant des adduits GSH-S-conjugu\u00e9s qui sont ensuite trait\u00e9s par la \u03b3-GT et les dipeptidases en acides mercapturiques et excr\u00e9t\u00e9s. C'est la voie centrale de d\u00e9toxification de phase II dans le foie et d'autres tissus, traitant une vaste gamme de x\u00e9nobiotiques (m\u00e9tabolites de m\u00e9dicaments, produits chimiques environnementaux, produits du m\u00e9tabolisme de phase I par le cytochrome P450), d'\u00e9lectrophiles endog\u00e8nes (4-hydroxynon\u00e9nal, acrol\u00e9ine provenant de la peroxydation lipidique) et d'interm\u00e9diaires r\u00e9actifs (NAPQI issu du parac\u00e9tamol, base de la th\u00e9rapie par NAC en cas de surdosage en parac\u00e9tamol).<\/li>\n<li><strong>Tampon de statut redox \u2014 r\u00e9gulation de l'\u00e9quilibre thiol-disulfure des prot\u00e9ines<\/strong> \u2014 The cellular GSH:GSSG ratio sets the thermodynamic equilibrium for protein-thiol redox state via thioredoxin- and glutaredoxin-mediated exchange. Thousands of cellular proteins have redox-sensitive cysteine residues whose thiol-disulfide state is regulated by this equilibrium \u2014 including key transcription factors (NF-\u03baB, AP-1, Nrf2, p53), signalling kinases (PTPs, PTEN), apoptosis machinery (caspases), and metabolic enzymes (glyceraldehyde-3-phosphate dehydrogenase, others). GSH-mediated redox buffering is therefore not just an antioxidant defence but a signalling regulatory mechanism \u2014 a fact that has emerged in published studies over the past two decades and is one of the most-cited rationales for the use of GSH in protocols beyond simple antioxidant supplementation.<\/li>\n<li><strong>R\u00e9servoir de cyst\u00e9ine et trafic inter-organes des acides amin\u00e9s<\/strong> \u2014 Le GSH sert de r\u00e9servoir tissulaire stable et transportable de cyst\u00e9ine \u2014 l'acide amin\u00e9 limitant pour la synth\u00e8se de nouvelles prot\u00e9ines et pour la synth\u00e8se suppl\u00e9mentaire de GSH. La cyst\u00e9ine sous forme libre est m\u00e9taboliquement instable (s'auto-oxydant en cystine, peut g\u00e9n\u00e9rer H<sub>2<\/sub>S, etc.), donc le corps maintient son pool de cyst\u00e9ine principalement sous forme de GSH et transporte la cyst\u00e9ine entre les organes (notamment foie \u2192 rein, foie \u2192 autres tissus) sous forme de GSH qui est ensuite retransform\u00e9e en cyst\u00e9ine par la \u03b3-GT au niveau du tissu cible.<\/li>\n<li><strong>Pi\u00e9geage direct des radicaux<\/strong> \u2014 Au-del\u00e0 des r\u00f4les enzymatiques, le GSH r\u00e9agit directement avec le radical hydroxyle, le radical peroxyle et les esp\u00e8ces r\u00e9actives de l'azote via le groupe thiol. Quantitativement, cela contribue moins \u00e0 la d\u00e9fense antioxydante totale que le m\u00e9canisme enzymatique m\u00e9di\u00e9 par la GPx, mais est important dans les compartiments et conditions o\u00f9 les syst\u00e8mes enzymatiques sont satur\u00e9s ou absents (GSH extracellulaire dans le liquide de rev\u00eatement pulmonaire, GSH de la lumi\u00e8re intestinale, etc.).<\/li>\n<\/ul>\n<p>The pharmacokinetic profile of injectable GSH is well-characterised: IV administration produces rapid systemic distribution with peak plasma concentrations within minutes, but plasma half-life is short (~10\u201315 minutes) due to rapid \u03b3-GT-mediated breakdown to cysteinylglycine and subsequent re-synthesis or further breakdown at target tissues. The brief plasma residence is one of the reasons why daily or twice-daily IV dosing protocols are common in published GSH studies. Cell-membrane permeability of intact GSH is low \u2014 cells primarily import the constituent amino acids and re-synthesise GSH intracellularly. This is why oral GSH is poorly bioavailable and why injectable preparations (or alternatively NAC as a cysteine prodrug) are required for effective tissue delivery in published studies. <\/p>\n<h2>Published Evidence<\/h2>\n<p>GSH is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>La d\u00e9fense antioxydante cellulaire \u2014 le compos\u00e9 de r\u00e9f\u00e9rence canonique<\/strong> \u2014 by far the most-cited cellular antioxidant in the published literature; standard reference compound for any new antioxidant intervention studies; the molecular gold standard for cellular redox-status analysis<\/li>\n<li><strong>Hydrogen peroxide and lipid peroxide reduction studies<\/strong> \u2014 direct GPx substrate; used in published studies on GPx isoform pharmacology, peroxide-handling pathway dissection, and the integration of GSH with thioredoxin and peroxiredoxin redox systems<\/li>\n<li><strong>Ferroptosis studies<\/strong> \u2014 GPx4-mediated lipid-hydroperoxide reduction is the gatekeeper of ferroptosis; GSH and its synthesis-pathway interventions (BSO, erastin, RSL3) are the canonical tools for ferroptosis induction \/ suppression studies in cancer, neurodegeneration, and ischaemia-reperfusion contexts<\/li>\n<li><strong>Phase II detoxification and xenobiotic-conjugation studies<\/strong> \u2014 GST substrate for the central liver-detoxification pathway; used in studies on drug-metabolite handling, environmental-chemical exposure, paracetamol-induced hepatotoxicity (NAPQI scavenging), and the broader pharmacology of mercapturic-acid conjugation<\/li>\n<li><strong>Protein-thiol redox signalling studies<\/strong> \u2014 the GSH:GSSG ratio controls thiol-disulfide equilibrium of thousands of cellular proteins; used in studies on redox-sensitive transcription factors (Nrf2, NF-\u03baB, AP-1), kinase regulation (PTPs, PTEN), and the broader cellular &#8220;redoxome&#8221;<\/li>\n<li><strong>Mitochondrial dysfunction and ageing studies<\/strong> \u2014 mitochondrial GSH levels decline with age and in many disease models; published studies uses exogenous GSH and GSH-pathway interventions to probe mitochondrial-redox contributions to ageing, neurodegeneration, and metabolic disease<\/li>\n<li><strong>Hepatology and liver-injury studies<\/strong> \u2014 GSH is most abundant in hepatocytes (5\u201310 mM concentration); used in published studies on alcoholic liver disease, NAFLD\/MASH, viral hepatitis models, and paracetamol-overdose \/ drug-induced liver injury<\/li>\n<li><strong>Hematology and erythrocyte studies<\/strong> \u2014 erythrocyte GSH is the major defence against oxidative haemolysis; used in studies on G6PD deficiency, sickle-cell disease, oxidative haemolysis pharmacology<\/li>\n<li><strong>Cancer redox and chemoprotection studies<\/strong> \u2014 many chemotherapeutic drugs generate ROS as part of their mechanism, and tumour cells often have elevated GSH levels; published studies uses GSH and GSH-pathway interventions to dissect chemotherapy redox biology<\/li>\n<\/ul>\n<p>For broader context on cellular cofactor and redox \/ antioxidant compounds in this catalogue, see <a href=\"https:\/\/medsbase.com\/fr\/b12-cyanocobalamin\/\">B12 (Cyanocobalamine)<\/a> (small-molecule companion cofactor \u2014 methylation cycle), <a href=\"https:\/\/medsbase.com\/fr\/l-carnitine\/\">L-Carnitine<\/a> (navette mitochondriale des acides gras \u2014 petite mol\u00e9cule compagnon), <a href=\"https:\/\/medsbase.com\/fr\/nad\/\">NAD\u207a<\/a> (suppl\u00e9mentation directe du pool de dinucl\u00e9otides \u2014 transport d'\u00e9lectrons redox), <a href=\"https:\/\/medsbase.com\/fr\/5-amino-1mq\/\">5-Amino-1MQ<\/a> (\u00e9pargne de l'axe NAD via inhibition de NNMT), et <a href=\"https:\/\/medsbase.com\/fr\/ss-31-elamipretide\/\">SS-31 (Elamipretide)<\/a> (peptide antioxydant mitochondriale cibl\u00e9 liant la cardiolipine). Parcourez l'int\u00e9gralit\u00e9 <a href=\"https:\/\/medsbase.com\/fr\/peptides\/\">peptides &amp; compounds catalog<\/a>, ou consultez la s\u00e9lection de <a href=\"https:\/\/medsbase.com\/fr\/best-longevity-peptides\/\">longevity compounds<\/a> hub. <\/p>\n<h2>Forces et concentrations disponibles<\/h2>\n<p>MedsBase stocks Glutathione in three lyophilized vial sizes calibrated to typical protocol dose ranges. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Concentration du flacon<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Cas d'utilisation typique<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tailles de conditionnement<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>600 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 entry-level protocols, in-vitro antioxidant-defence panels, dose-titration work, single-cohort murine titration; convenient for reconstitution at 100\u2013200 mg\/mL working stocks<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>900 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Mid-strength \u2014 extended in-vivo rodent dosing protocols, IV-protocols, multi-cohort sample sizes, hepatology \/ oxidative-stress model studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>1500 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">High-strength vial \u2014 clinical-translational dose-range protocols (Italian Tationil IV dosing is 600\u20132400 mg\/d for hepatology studies), large-cohort metabolic studies, multi-arm comparator work; lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical entity (lyophilized L-glutathione reduced form, \u226599% HPLC purity, USP-grade titration-confirmed reduced-form content). The 1500 mg vial provides the lowest per-mg cost for clinical-translational protocols. Users should determine specific dose ranges from peer-reviewed literature appropriate to the protocol. <\/p>\n<h2>Comparaison \u2014 Glutathion vs NAD\u207a<\/h2>\n<p>Le glutathion et <a href=\"https:\/\/medsbase.com\/fr\/nad\/\">NAD\u207a<\/a> sont les deux compos\u00e9s redox \/ coenzymes cellulaires \u00e0 petite mol\u00e9cule les plus \u00e9tudi\u00e9s dans ce catalogue, et ils se situent sur des branches connect\u00e9es mais m\u00e9canistiquement distinctes de la biologie redox cellulaire. Le GSH est le ma\u00eetre <em>d\u00e9fense antioxydante cellulaire<\/em> petite mol\u00e9cule \u2014 pr\u00e9sente \u00e0 des concentrations millimolaires et r\u00e9duisant les peroxydes via le m\u00e9canisme de substrat GPx. Le NAD\u207a est le ma\u00eetre <em>transport d'\u00e9lectrons cellulaire<\/em> coenzyme \u2014 reducible to NADH for electron transport in glycolysis \/ TCA cycle \/ \u03b2-oxidation, and substrate for sirtuins and PARPs. The two systems are interconnected: NADPH (made from NAD via the pentose phosphate pathway) is the reducing equivalent that regenerates GSH from GSSG via glutathione reductase. Studies that probes cellular redox biology often manipulates both pools and compares the consequences. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e8re<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Glutathion (GSH)<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">NAD\u207a<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Classe chimique<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Tripeptide \u03b3-glutamyle (\u03b3-Glu-Cys-Gly)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Coenzyme dinucl\u00e9otide (ad\u00e9nine + nicotinamide + diphosphate)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Masse mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">307,32 g\/mol<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">663,43 g\/mol<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>R\u00f4le cellulaire<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">D\u00e9fense antioxydante \u2014 substrat GPx (r\u00e9duction des peroxydes), co-substrat GST (conjugaison des x\u00e9nobiotiques), tampon du statut redox<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Coenzyme de transport d'\u00e9lectrons \u2014 substrat pour la \u03b2-oxydation, la glycolyse, le cycle TCA ; substrat pour les sirtuines et PARPs<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Concentration cellulaire<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\u201310 mM (millimolaire \u2014 thiol non prot\u00e9ique le plus abondant)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~0,3\u20131 mM (pool NAD, micromolaire \u00e0 \u00b5M \u00e9lev\u00e9)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Best-studied studies focus<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">D\u00e9fense antioxydante, ferroptose, d\u00e9toxification de phase II, signalisation redox, h\u00e9patologie, l\u00e9sion induite par le parac\u00e9tamol<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Biologie des sirtuines, long\u00e9vit\u00e9, vieillissement cellulaire, r\u00e9gulation redox de l'axe NAD<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Stabilit\u00e9 plasmatique<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Court \u2014 demi-vie d'environ 10\u201315 min (d\u00e9gradation extracellulaire m\u00e9di\u00e9e par la \u03b3-GT)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Tr\u00e8s court \u2014 quelques minutes (s'oxyde et se d\u00e9grade rapidement en solution)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Connexion<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Le NADPH (d\u00e9riv\u00e9 du NAD) r\u00e9g\u00e9n\u00e8re le GSH \u00e0 partir du GSSG via la glutathion r\u00e9ductase<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">La connexion NADPH relie le pool de NAD \u00e0 la capacit\u00e9 de r\u00e9duction du syst\u00e8me GSH<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Utilisation clinique<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Injectable approuv\u00e9 en Italie \/ Japon \/ Cor\u00e9e (Tationil et similaires ; h\u00e9patologie, stress oxydatif)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Not approved as a clinical therapeutic; studies-only compound<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For studies focused on cellular antioxidant defence, ferroptosis, Phase II detoxification, or redox signalling, Glutathione is the canonical reference compound. For studies focused on sirtuin biology, longevity-axis biochemistry, or NAD-dependent redox regulation, <a href=\"https:\/\/medsbase.com\/fr\/nad\/\">NAD\u207a<\/a> is the more targeted tool. The two compounds are commonly co-administered in studies that probes the integrated cellular-redox-system response to oxidative stress, ageing, or mitochondrial dysfunction. <\/p>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 14px 18px; margin: 18px 0;\"><strong class=\"mb-bac-water-callout\">\ud83d\udca7 Besoin d'eau BAC ?<\/strong> La reconstitution de tout flacon lyophilis\u00e9 n\u00e9cessite de l'eau bact\u00e9riostatique st\u00e9rile. Associez ce produit \u00e0 notre <a href=\"\/fr\/bac-water\/\"><strong>Eau BAC (Eau bact\u00e9riostatique)<\/strong><\/a> \u2014 flacon multidose de 30 mL, pr\u00e9serv\u00e9 par 0,9 % d'alcool benzylique, qualit\u00e9 USP.<\/div>\n<h2>Stockage et reconstitution<\/h2>\n<p><strong>Avant la reconstitution :<\/strong> conserver les flacons lyophilis\u00e9s au r\u00e9frig\u00e9rateur entre 2 et 8 \u00b0C dans leur emballage d'origine scell\u00e9. Pour un stockage \u00e0 long terme, congeler les flacons non ouverts \u00e0 \u221220 \u00b0C (stable \u226536 mois \u00e0 \u221220 \u00b0C ; \u226518 mois entre 2 et 8 \u00b0C). Le GSH lyophilis\u00e9 est <strong>tr\u00e8s hygroscopique<\/strong> \u2014 refermez imm\u00e9diatement les flacons apr\u00e8s chaque pr\u00e9l\u00e8vement pour \u00e9viter l'absorption d'humidit\u00e9 (ce qui acc\u00e9l\u00e8re l'oxydation GSH \u2192 GSSG). Prot\u00e9gez de la lumi\u00e8re. <strong>Proc\u00e9dure de reconstitution :<\/strong> Injectez de l'eau st\u00e9rile, de l'eau bact\u00e9riostatique ou du PBS (pH 7,2) le long de la paroi lat\u00e9rale du flacon (pas directement sur le g\u00e2teau lyophilis\u00e9). Pour un flacon de 600 mg, 6,0 mL de diluant donnent une solution de travail \u00e0 100 mg\/mL ; 3,0 mL donnent 200 mg\/mL. Pour un flacon de 900 mg, 9,0 mL donnent 100 mg\/mL ; 4,5 mL donnent 200 mg\/mL. Pour un flacon de 1500 mg, 7,5 mL donnent une solution \u00e0 200 mg\/mL ; 15 mL donnent 100 mg\/mL. Le GSH se dissout rapidement par un l\u00e9ger mouvement circulaire \u00e0 temp\u00e9rature ambiante. <strong>Critique pour le GSH reconstitu\u00e9 :<\/strong> le groupe thiol (-SH) est <strong>sensible \u00e0 l'oxydation par l'air<\/strong> \u2014 les solutions reconstitu\u00e9es s'oxydent progressivement en forme GSSG, m\u00eame r\u00e9frig\u00e9r\u00e9es. Pr\u00e9parez des solutions de travail fra\u00eeches \u00e0 partir de flacons lyophilis\u00e9s si possible, ou utilisez dans les 7 jours suivant la reconstitution au r\u00e9frig\u00e9rateur. Pour un stockage \u00e0 long terme du mat\u00e9riel reconstitu\u00e9, ajoutez des ch\u00e9lateurs (1 mM EDTA) pour ralentir l'oxydation catalys\u00e9e par les m\u00e9taux, stockez sous atmosph\u00e8re inerte (argon ou azote) ou utilisez un co-solvant DMSO (qui offre une protection suppl\u00e9mentaire). Ne pas congeler-d\u00e9congeler \u00e0 r\u00e9p\u00e9tition. Jetez en cas de changement de couleur marqu\u00e9 (jaune \/ brun) ou d'apparition de pr\u00e9cipit\u00e9. <\/p>\n<h2>Questions fr\u00e9quemment pos\u00e9es<\/h2>\n<h3>Quelle est la diff\u00e9rence entre le glutathion r\u00e9duit (GSH) et oxyd\u00e9 (GSSG) ?<\/h3>\n<p>GSH is the reduced form with a free thiol (-SH) group on its cysteine residue \u2014 the biologically active form that serves as the cellular antioxidant. GSSG is the oxidised dimer form where two GSH molecules are linked through their cysteine sulfurs by a disulfide bridge \u2014 the spent form that needs to be re-reduced to 2 GSH by glutathione reductase. The cellular GSH:GSSG ratio (typically ~100:1 in healthy cells, dropping to 10:1 or lower under oxidative stress) is the canonical biomarker of cellular redox status. We supply the reduced GSH form; users requiring GSSG specifically should consult dedicated suppliers. <\/p>\n<h3>Pourquoi le GSH a-t-il une liaison \u03b3-peptidique au lieu d'une liaison \u03b1-peptidique normale ?<\/h3>\n<p>La liaison \u03b3-peptidique non standard entre le \u03b3-COOH du glutamate et le \u03b1-NH de la cyst\u00e9ine<sub>2<\/sub> est ce qui conf\u00e8re au glutathion sa r\u00e9sistance aux peptidases cellulaires. Les \u03b1-peptidases cellulaires standards (aminopeptidases, carboxypeptidases) ne reconnaissent que les liaisons \u03b1-peptidiques et ne peuvent cliver la liaison \u03b3. Seule la \u03b3-glutamyltransf\u00e9rase (\u03b3-GT, GGT) reconna\u00eet et clive la liaison \u03b3 \u2014 et la \u03b3-GT est l'enzyme limitante de la d\u00e9gradation du GSH, exprim\u00e9e principalement \u00e0 la surface apicale des cellules \u00e9pith\u00e9liales (rein, voies biliaires, etc.). Cette liaison non standard est donc essentielle pour l'accumulation intracellulaire stable du glutathion \u00e0 des concentrations millimolaires. <\/p>\n<h3>Pourquoi la biodisponibilit\u00e9 orale du GSH est-elle faible ?<\/h3>\n<p>Intact GSH is poorly absorbed across the intestinal epithelium because: (1) the \u03b3-peptide bond prevents recognition by the standard PEPT1 \/ PEPT2 di-\/tri-peptide transporters that absorb other tripeptides; (2) \u03b3-GT activity at the brush border degrades much of the orally-administered GSH to its constituent amino acids before absorption; (3) the cysteine that is liberated is then largely consumed by enterocyte first-pass GSH re-synthesis. The net oral bioavailability of intact GSH is therefore very low, which is why injectable preparations or N-acetylcysteine (NAC, a cysteine prodrug) are preferred for systemic GSH-boosting studies interventions. <\/p>\n<h3>What published dose ranges have been used in studies?<\/h3>\n<p>Injectable IV GSH protocol dosing typically uses 600\u20131200 mg per dose, daily or 2\u20133\u00d7\/week, for 4\u201312 weeks in human-subject studies (mirroring the Italian Tationil approved-product dose range of 600\u20132400 mg\/d). Rodent in-vivo work uses 50\u2013150 mg\/kg IV \/ IP, mirroring the dose range that produces reliable systemic GSH elevation despite the short plasma half-life. In-vitro cell-culture protocols typically use 0.5\u201310 mM in growth medium (cells take up cysteine from GSH and re-synthesise intracellular GSH). Users should consult primary literature appropriate to the specific application. <\/p>\n<h3>Pourquoi la demi-vie plasmatique du GSH est-elle si courte ?<\/h3>\n<p>Plasma \u03b3-GT activity rapidly cleaves the \u03b3-peptide bond of circulating GSH to cysteinylglycine, which is then further cleaved by dipeptidases to cysteine + glycine. The combined \u03b3-GT + dipeptidase cascade gives intact circulating GSH a plasma half-life of only ~10\u201315 minutes. This is why repeated daily dosing is used in clinical-protocols rather than single high-dose bolus regimens, and why N-acetylcysteine (NAC) \u2014 which is taken up intact and used for intracellular GSH synthesis \u2014 is sometimes preferred as a longer-acting cysteine-source alternative for cellular GSH boosting studies. <\/p>\n<h3>Can GSH be combined with B12, NAC, or other redox \/ cofactor compounds in protocols?<\/h3>\n<p>Yes \u2014 GSH is mechanistically connected to many other cellular-redox and cofactor compounds. Common protocol combinations include: GSH + NAC (parallel cysteine-source strategies \u2014 GSH as the intact tripeptide, NAC as the cysteine prodrug \u2014 to compare extracellular vs intracellular GSH-supplementation routes); GSH + <a href=\"https:\/\/medsbase.com\/fr\/b12-cyanocobalamin\/\">B12<\/a> (oxidative-stress-related neurology and methylation-cycle studies); GSH + <a href=\"https:\/\/medsbase.com\/fr\/nad\/\">NAD\u207a<\/a> (dissection int\u00e9gr\u00e9e du pool redox) ; GSH + <a href=\"https:\/\/medsbase.com\/fr\/ss-31-elamipretide\/\">SS-31<\/a> (mitochondrial-targeted redox studies). Reconstitute each separately just before use and add separately rather than co-storing reconstituted solutions. <\/p>\n<h3>How does this pharmaceutical-grade GSH compare with clinical preparations like Tationil?<\/h3>\n<p>Tationil (and similar branded clinical preparations available in Italy \/ Japan \/ Korea \/ Philippines) is reduced-form L-glutathione approved as a clinical injectable for hepatology and oxidative-stress indications. The pharmaceutical-grade GSH supplied here is the same reduced-form L-glutathione at \u226599% HPLC purity, supplied without a clinical-use label and intended for clinical studies only. Users seeking clinical-use GSH should obtain it through a clinical supply chain; users seeking pharmaceutical-grade material for in-vitro and in-vivo clinical protocols can use the material supplied here. <\/p>\n<h3>Le GSH figure-t-il sur la liste des substances interdites par l'AMA ?<\/h3>\n<p>Non. Le glutathion ne figure pas sur la Liste des substances interdites de l'AMA. C'est un tripeptide antioxydant cellulaire naturellement pr\u00e9sent \u00e0 des concentrations millimolaires dans chaque cellule nucl\u00e9\u00e9e \u2014 donc non soumis aux restrictions r\u00e9glementaires sur la performance athl\u00e9tique. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Small-Molecule Companion Compounds<\/h2>\n<ul>\n<li><a href=\"\/fr\/b12-cyanocobalamin\/\"><strong>B12 (Cyanocobalamine)<\/strong><\/a> \u2014 Cobalamin coenzyme \u2014 methylation-cycle companion<\/li>\n<li><a href=\"\/fr\/l-carnitine\/\"><strong>L-Carnitine<\/strong><\/a> \u2014 Mitochondrial fatty-acid shuttle \u2014 closest small-molecule companion analogue<\/li>\n<li><a href=\"\/fr\/nad\/\"><strong>NAD\u207a<\/strong><\/a> \u2014 Oxidised dinucleotide coenzyme \u2014 direct NAD-pool \/ electron-transport studies<\/li>\n<li><a href=\"\/fr\/5-amino-1mq\/\"><strong>5-Amino-1MQ<\/strong><\/a> \u2014 Inhibiteur de NNMT \u2014 \u00e9pargne des pr\u00e9curseurs de l'axe NAD, tamponnage du pool de m\u00e9thylation<\/li>\n<li><a href=\"\/fr\/ss-31-elamipretide\/\"><strong>SS-31 (Elamipretide)<\/strong><\/a> \u2014 Peptide antioxydant mitochondrial cibl\u00e9 liant la cardiolipine<\/li>\n<li><a href=\"\/fr\/bac-water\/\"><strong>Eau BAC (Eau bact\u00e9riostatique)<\/strong><\/a> \u2014 N\u00e9cessaire pour reconstituer tout flacon lyophilis\u00e9 \u2014 diluant st\u00e9rile, conserv\u00e9 avec 0,9% d'alcool benzylique<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Tripeptide \u03b3-glutamyle (\u03b3-Glu-Cys-Gly) \u2014 thiol non prot\u00e9ique cellulaire primaire<br \/>\n\u2705 Substrat de GPx (r\u00e9duction des peroxydes) + co-substrat de GST (conjugaison des x\u00e9nobiotiques) + tampon de statut redox<br \/>\n\u2705 Liaison peptidique \u03b3 unique \u2014 r\u00e9sistante aux peptidases ; seule la \u03b3-GT la clive<br \/>\n\u2705 Canonical reference compound for cellular antioxidant defence studies<br \/>\n\u2705 Forme r\u00e9duite lyophilis\u00e9e de qualit\u00e9 USP ; CAS 70-18-8, MW 307.32<\/p>\n<p><strong>L-Glutathion (R\u00e9duit \/ GSH)<\/strong> contains the \u03b3-glutamyl-cysteinyl-glycine tripeptide compound.<\/p>","protected":false},"featured_media":71535,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6517,6516,5737,4442,6519,6494,6518],"class_list":["post-71470","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-antioxidant-peptide","product_tag-glutathione-reduced","product_tag-gsh","product_tag-l-glutathione","product_tag-redox-research","product_tag-research-peptide","product_tag-tripeptide-research-compound","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product\/71470","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/comments?post=71470"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media\/71535"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media?parent=71470"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_brand?post=71470"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_cat?post=71470"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_tag?post=71470"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}